Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. Qadri S, Ahlholm N, Lonsmann I, Pellegrini P, et al. J Clin Endocrinol Metab 2021 Dec 31. pii: 6491221. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Qadri S, Ahlholm N, Lonsmann I, Pellegrini P, et al. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab 2021 Dec 31. pii: 6491221. doi: 10.1210.
PMID: 34971370